Daehan New Pharm Co. Ltd (054670) — Financial Flexibility Index
Daehan New Pharm Co. Ltd (054670) has a Financial Flexibility Index of 0.13x as of September 2025. Free cash flow of ₩15.96 Billion (operating CF ₩4.43 Billion minus capex ₩11.53 Billion) represents 0% of total liabilities (₩122.10 Billion). Check Daehan New Pharm Co. Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Daehan New Pharm Co. Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Daehan New Pharm Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see how efficiently does Daehan New Pharm Co. Ltd generate cash.
Annual Financial Flexibility Index for Daehan New Pharm Co. Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for Daehan New Pharm Co. Ltd. Explore cash flow to debt ratio of Daehan New Pharm Co. Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.56x | ₩53.20 Billion | ₩18.95 Billion | ₩95.85 Billion | ▲ +66.7% |
| 2023 | 0.33x | ₩22.50 Billion | ₩12.57 Billion | ₩67.57 Billion | ▲ +24.4% |
| 2022 | 0.27x | ₩17.77 Billion | ₩14.25 Billion | ₩66.40 Billion | ▼ -25.9% |
| 2021 | 0.36x | ₩27.14 Billion | ₩16.58 Billion | ₩75.18 Billion | ▲ +19.1% |
| 2020 | 0.30x | ₩23.01 Billion | ₩13.55 Billion | ₩75.95 Billion | ▼ -36.7% |
| 2019 | 0.48x | ₩31.97 Billion | ₩22.89 Billion | ₩66.84 Billion | ▲ +41.4% |
| 2018 | 0.34x | ₩22.21 Billion | ₩20.47 Billion | ₩65.66 Billion | ▲ +2122.9% |
| 2017 | -0.02x | ₩-1.17 Billion | ₩-2.42 Billion | ₩70.09 Billion | ▼ -107.5% |
| 2016 | 0.22x | ₩13.32 Billion | ₩8.75 Billion | ₩59.52 Billion | ▲ +6.3% |
| 2015 | 0.21x | ₩11.67 Billion | ₩7.80 Billion | ₩55.43 Billion | ▼ -28.7% |
| 2014 | 0.30x | ₩16.71 Billion | ₩10.02 Billion | ₩56.58 Billion | — |